Comprehensive Genomic Tumor Profiling

from Illumina Genomics Podcast · host Illumina Genomics Podcast

NGS-based genomics assays can help characterize the genetic profile of a tumor, and these technologies are poised to supplant single-gene testing in oncology. But, what impact will this revolutionary technology have on patients, clinicians, and the entire healthcare system? Listen to Dr. Brian Piening of the Providence Cancer Institute explain how NGS is changing the standard of care in oncology.

Episode metadata supplied by the publisher feed · Published Dec 11, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Comprehensive Genomic Tumor Profiling

0:00 19:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Illumina Genomics Podcast?

This episode is 19 minutes long.

When was this Illumina Genomics Podcast episode published?

This episode was published on December 11, 2019.

Can I download this Illumina Genomics Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!